HomeAI · summaries
Storia in 2 fonti
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
cryptobriefing.com
Insilico Medicine's rentosertib shows potential to slow aging in landmark Phase III trial
Insilico Medicine's AI-discovered drug rentosertib enters Phase III trials for lung fibrosis, targeting cellular senescence with implications for
- ·
morningstar.com
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug